KPCB XV Associates

KPCB XV Associates as of Sept. 30, 2022

Portfolio Holdings for KPCB XV Associates

KPCB XV Associates holds 3 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rapt Therapeutics Common Stock (RAPT) 43.5 $16M 649k 24.06
Twilio Class A Common Stock (TWLO) 36.7 $13M 190k 69.14
Atara Biotherapeutics Common Stock 19.8 $7.1M 1.9M 3.78